Telesis Bio (TBIO) Projected to Post Earnings on Tuesday

Telesis Bio (OTCMKTS:TBIO – Get Free Report) is anticipated to post its results on Tuesday, November 17th. Analysts expect Telesis Bio to post earnings of ($6.39) per share and revenue of $2.53 million for the quarter.

Telesis Bio Price Performance

Shares of TBIO opened at $0.01 on Monday. The company has a market cap of $18,000.00, a PE ratio of -0.00 and a beta of -14.02. The business has a fifty day moving average of $0.01 and a 200 day moving average of $0.03. Telesis Bio has a 52-week low of $0.00 and a 52-week high of $0.15.

About Telesis Bio

(Get Free Report)

Telesis Bio, Inc. develops automated synthetic biology systems designed to help researchers create and test biological molecules more efficiently. Its technology is intended to streamline the design-build-test process by automating tasks that traditionally require multiple manual laboratory steps. The company’s primary products include the BioXp automated benchtop platforms and related consumables, software, and application-specific kits. These systems support the on-demand synthesis and assembly of DNA, messenger RNA and other biological constructs for applications such as gene and cell therapy research, vaccine development, protein engineering, diagnostics and synthetic biology.

Read More

Earnings History for Telesis Bio (OTCMKTS:TBIO)

Receive News & Ratings for Telesis Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telesis Bio and related companies with MarketBeat.com's FREE daily email newsletter.